Details for New Drug Application (NDA): 213949
✉ Email this page to a colleague
The generic ingredient in LAMOTRIGINE is lamotrigine. There are thirty-two drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the lamotrigine profile page.
Summary for 213949
Tradename: | LAMOTRIGINE |
Applicant: | Yiling |
Ingredient: | lamotrigine |
Patents: | 0 |
Pharmacology for NDA: 213949
Mechanism of Action | Dihydrofolate Reductase Inhibitors Organic Cation Transporter 2 Inhibitors |
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 213949
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LAMOTRIGINE | lamotrigine | TABLET, EXTENDED RELEASE;ORAL | 213949 | ANDA | Camber Pharmaceuticals Inc | 31722-240 | 31722-240-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-240-30) |
LAMOTRIGINE | lamotrigine | TABLET, EXTENDED RELEASE;ORAL | 213949 | ANDA | Camber Pharmaceuticals Inc | 31722-241 | 31722-241-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-241-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 25MG | ||||
Approval Date: | Dec 8, 2021 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 50MG | ||||
Approval Date: | Dec 8, 2021 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 100MG | ||||
Approval Date: | Dec 8, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription